AIM RX 3PL, LLC — Sodium Importer Profile
Pharmaceutical Importer · #10 buyer for Sodium · $5.3M import value · 115 shipments · UNITED STATES · DGFT Verified
AIM RX 3PL, LLC is the #10 importer of Sodium from India with $5.3M in import value and 115 verified shipments. AIM RX 3PL, LLC holds a 1.0% market share in Sodium imports based in UNITED STATES. The company sources from 1 verified supplier across 13 formulations shipped to 1 country. Overall, AIM RX 3PL, LLC imports 4 pharmaceutical products worth $13.4M across 4 therapeutic categories.
AIM RX 3PL, LLC — Sodium Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Sodium to AIM RX 3PL, LLC?
Verified from 115 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| ENCUBE ETHICALS PRIVATE LIMITED | $5.3M | 115 | 100.0% |
AIM RX 3PL, LLC sources Sodium from 1 verified Indian supplier based on 115 customs records. The primary supplier is ENCUBE ETHICALS PRIVATE LIMITED accounting for 100.0% of imports.
How Does AIM RX 3PL, LLC Compare to Nearest Sodium Importers?
Buyers ranked immediately above and below #10 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 15 | FRESENIUS KABI CANADA LTD | CANADA | $4.0M | 80 | $50.0K |
| 11 | DR. REDDYS LABORATORIES, INC | UNITED STATES | $3.9M | 78 | $50.0K |
| 10 | AIM RX 3PL, LLC ★ | UNITED STATES | $3.6M | 73 | $50.0K |
| 1 | AUROLOGISTICS LLC (AUROMEDICS PHARM | UNITED STATES | $3.5M | 69 | $50.0K |
| 6 | AUROLOGISTIC LLC,(AUROMEDICS PHARMA | UNITED STATES | $3.4M | 68 | $50.0K |
AIM RX 3PL, LLC ranks #10 among 2,469 Sodium importers from India. Average shipment value of $50.0K compared to the market average of $24.1K. The closest competitors by value are FRESENIUS KABI CANADA LTD and DR. REDDYS LABORATORIES, INC.
Where Does AIM RX 3PL, LLC Import Sodium To?
Destination countries from 115 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $5.3M | 115 | 100.0% |
AIM RX 3PL, LLC imports Sodium to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $5.3M.
What Sodium Formulations Does AIM RX 3PL, LLC Import?
| Formulation | Value | Shipments |
|---|---|---|
| DICLOFENAC SODIUM TOPICAL GEL 1% LAMI 10 | $4.6M | 99 |
| DICLOFENAC SODIUM TOPICAL GEL 1 % LAMI 1 | $201.0K | 5 |
| DICLOFENAC SODIUM TOPICAL GEL 1% LAMI 150G BATCH NO.3DN05 MFGR DEC 2023 EXP DT.NOV 2025NOS | $50.0K | 1 |
| DICLOFENAC SODIUM TOPICAL GEL 1% LAMI 100 BATCH NO.4DN06 MFG DT.MAY 2024 EXP DT.APR 2026 | $50.0K | 1 |
| DICLOFENAC SODIUM TOPICAL GEL 1% USP 100G-OTC B.NO. 5KA01,5KA02,5KA03,5KA04 MFGDT. JAN 2025 EXP DT. DEC 2026 | $50.0K | 1 |
| DICLOFENAC SODIUM TOPICAL GEL 1% USP 100G-OTC B.NO.5KA06 & 5KA05 MFG DT. JAN 2025 EXP DT. DEC 2026 | $50.0K | 1 |
| DICLOFENAC SODIUM TOPICAL GEL 1% LAMI 150G B.NO.5DN01,5DN02 MFG DT. FEB 2025 EXPDT. JAN 2027 | $50.0K | 1 |
| DICLOFENAC SODIUM TOPICAL GEL 1% LAMI 150G B.NO.5DN04,5DN05 MFG DT. FEB 2025 EXPDT. JAN 2027 | $50.0K | 1 |
| DICLOFENAC SODIUM TOPICAL GEL 1% LAMI 150G B.NO.5DN03 MFG DT. FEB 2025 EXP DT. JAN 2027 | $50.0K | 1 |
| DICLOFENAC SODIUM TOPICAL GEL 1% LAMI 150G B.NO. 5DN07 MFG DT. FEB 2025 EXP DT.JAN 2027 | $50.0K | 1 |
AIM RX 3PL, LLC imports 13 distinct Sodium formulations from India. The top formulation is DICLOFENAC SODIUM TOPICAL GEL 1% LAMI 10 with 99 shipments worth $4.6M.
Regulatory Requirements: Importing Sodium into United States
What AIM RX 3PL, LLC and other importers must comply with to import Sodium from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Sodium
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Sodium from India and How Much Does AIM RX 3PL, LLC Import?
India exported $59.4M worth of Sodium through 15,000 shipments from 985 suppliers to 177 countries, serving 2,469 buyers globally. AIM RX 3PL, LLC imports $5.3M of this total, accounting for 1.0% of India's Sodium exports with 115 shipments from UNITED STATES. This is verified from 115 customs shipment records covering 13 distinct formulations.
What Is the Average Order Value for AIM RX 3PL, LLC's Sodium Imports?
AIM RX 3PL, LLC's average Sodium order value is $46.0K per consignment, based on 115 shipments totaling $5.3M. AIM RX 3PL, LLC is based in UNITED STATES and ranks #10 among all Sodium importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Sodium to AIM RX 3PL, LLC?
AIM RX 3PL, LLC sources Sodium from 1 verified Indian supplier: ENCUBE ETHICALS PRIVATE LIMITED ($5.3M, 100.0%). This is based on 115 customs records.
How Does AIM RX 3PL, LLC Compare to Other Sodium Importers?
AIM RX 3PL, LLC ranks #10 among 2,469 Sodium importers from India with a 1.0% market share. The top 3 importers are CIPLA USA INC UPS SUPPLY CHAIN SOLU ($10.7M), UNICHEM PHARMACEUTICALS (USA) INC. ($7.0M), PLANET PHARMA ($5.8M). AIM RX 3PL, LLC processed 115 shipments from UNITED STATES.
About AIM RX 3PL, LLC
AIM RX 3PL, LLC imports 4 products worth $13.4M. Beyond Sodium, top products include Diclofenac, Clindamycin, Ketoconazole. View the complete AIM RX 3PL, LLC profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Sodium — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Sodium shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: AIM RX 3PL, LLC matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as AIM RX 3PL, LLC's capped import value divided by total capped export value for Sodium across all Indian exporters.
- 5.Verified Records: This page is backed by 115 individual customs records matching AIM RX 3PL, LLC importing Sodium, covering 13 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 177+ countries, 2,469+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Sodium Import Data for AIM RX 3PL, LLC
Access order-level details, pricing data, supplier connections, and competitive analysis for AIM RX 3PL, LLC's Sodium imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
AIM RX 3PL, LLC
Full Company Profile →
4 products · $13.4M total trade · 4 categories
AIM RX 3PL, LLC × Sodium
Verified from customs records
Company Overview
Top Products by AIM RX 3PL, LLC
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for AIM RX 3PL, LLC.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Sodium. For current order-level data, contact TransData Nexus.